NRXS: NeurAxis Earnings growth forecast for next year
Optimizing the distribution of neuro-equipment through reliable partners supports high margins for NeurAxis, Inc. (NRXS). The EPS growth rate target for next year in the GURU.Markets terminal chart confirms this, where the 30.30 mark serves as the current indicator. Looking ahead, the expansion of IB-Stim into the adult market and integration with pediatric centers without mergers will ensure an organic inflow of capital.
NRXS (NeurAxis Inc.): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- market capitalization information:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital NeurAxis, Inc.|NRXS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity NeurAxis, Inc.|NRXS - Company Aggregate Debt|Debts to Book Capitalization NeurAxis, Inc|NRXS - Company Long-Term Liabilities|Company Current Liabilities NeurAxis|Quick Liquidity neuraxis.com
- net income and valuation ratios data:
NRXS - Company Profit|Expected Profit NeurAxis, Inc.|NRXS - Company Value to Net Income|Projected Price to Earnings NeurAxis, Inc|NRXS - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeurAxis Inc|NRXS - Operating income before deduction of amortization|Earnings per share for the last twelve months NeurAxis|NRXS - Earnings per share for the last 12 months|Quarterly EPS earnings growth neuraxis.com|NRXS - Earnings per share growth rate in current year|Expected earnings per share growth for next year NeurAxis, Inc.
- revenue and sales details:
General company analysis:neuraxis.com, NRXS
This indicator reflects the analysts' consensus forecast for net income changes, neutralizing reporting time lags by updating market expectations. For NeurAxis, Inc. (NRXS), the expansion of insurance coverage and demand for neuromodulation in pediatrics converts directly into potential EPS growth. An analysis of the earnings per share growth model for the coming year allows for an assessment of capital stability through the lens of future operational efficiency.
Analysis of competing companies
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Net earnings per share growth forecast for next year VTGN (VistaGen Therapeutics Inc)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Earnings growth forecast for next year Acumen Pharma ABOS|CervoMed, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Expected earnings per share growth for next year|Expected net earnings per share growth next year PepGen Corp (PEPG)|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Expected net earnings per share growth next year Relmada Therapeutics RLMD|Net earnings per share growth forecast for next year Annovis Bio (ANVS)|GRCE - Expected net earnings per share growth next year|Earnings growth forecast for next year AIFF (Firefly Neuroscience, Inc)|Klotho Neurosciences Inc (KLTO) - Expected net earnings per share growth next year|NeuroSense Therapeutics, Ltd. - Earnings growth forecast for next year|RVPH - Earnings growth forecast for next year|MetaVia Inc (MTVA) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
